HK Stock MarketDetailed Quotes

02500 VENUS MEDTECH-B

Watchlist
  • 5.620
  • 0.0000.00%
Not Open Dec 13 16:08 CST
2.48BMarket Cap-4.04P/E (TTM)

VENUS MEDTECH-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Assets
Current assets
Inventory
4.99%123.68M
8.19%112.94M
10.79%117.81M
15.33%104.4M
60.50%106.33M
51.11%90.52M
74.94%66.25M
141.66%59.9M
--37.87M
48.57%24.79M
Accounts receivable
-32.00%273.1M
-4.21%290.61M
19.44%401.62M
0.43%303.39M
-1.64%336.26M
30.76%302.1M
113.05%341.88M
42.44%231.03M
--160.47M
101.13%162.2M
Related party payments receivable
----
----
----
----
----
----
----
--22.5M
----
----
Advance deposits and other receivables
-26.38%94.55M
-12.35%105.07M
3.01%128.43M
34.33%119.87M
95.23%124.67M
155.07%89.23M
-43.01%63.86M
-88.47%34.98M
--112.06M
998.82%303.46M
Cash and equivalents
-66.57%485.84M
-58.80%774.4M
-40.32%1.45B
-36.40%1.88B
-31.98%2.44B
9.12%2.96B
81.76%3.58B
12.22%2.71B
--1.97B
1,363.34%2.41B
Short-term deposit
----
--7.24M
----
----
----
----
----
----
----
----
Secured deposit
81.21%9.43M
670.00%211.65M
8.92%5.2M
972.45%27.49M
-98.11%4.78M
-99.01%2.56M
-9.20%252.76M
34,714.48%259.72M
--278.36M
8.75%746K
Financial assets at fair value-current assets
----
----
----
----
----
----
----
--44.13M
----
----
Special items of current assets
--108.54M
208.63%106.17M
----
--34.4M
----
----
----
----
----
----
Total current assets
-48.00%1.1B
-34.87%1.61B
-29.96%2.11B
-28.22%2.47B
-30.14%3.01B
2.36%3.44B
68.26%4.3B
15.70%3.36B
--2.56B
899.34%2.9B
Non-current assets
Property, plant and equipment
56.31%568.12M
70.80%543.37M
40.83%363.46M
123.67%318.14M
144.41%258.09M
105.26%142.24M
58.20%105.6M
14.76%69.3M
--66.75M
29.21%60.38M
Advance payment
-21.09%3.39M
-42.31%9.15M
-81.75%4.3M
-6.35%15.86M
-29.82%23.57M
-38.03%16.93M
-50.59%33.58M
309.89%27.32M
--67.96M
262.23%6.67M
Associated company interest
-8.77%60.93M
-13.84%60.55M
-6.98%66.79M
-7.75%70.28M
-12.87%71.8M
100.51%76.18M
1,109.57%82.41M
--38M
--6.81M
----
Interests in Joint Venture
-21.34%4.18M
75.70%4.79M
--5.31M
--2.73M
----
----
----
----
----
----
Financial assets at fair value-non-current assets
3.95%430.81M
10.32%428.38M
53.08%414.45M
-18.62%388.32M
87.25%270.74M
640.08%477.16M
408.92%144.58M
--64.47M
--28.41M
----
Intangible assets
-11.52%531.34M
-9.84%551.02M
-40.26%600.55M
100.55%611.17M
340.97%1.01B
30.79%304.74M
14.93%227.97M
25.85%233M
--198.36M
-3.13%185.15M
Goodwill
-19.24%1.03B
-17.29%1.02B
-9.12%1.28B
138.31%1.24B
191.06%1.4B
6.65%519.71M
-7.98%482.5M
1.60%487.32M
--524.36M
1.65%479.63M
Deferred tax assets
56.82%21.26M
77.65%17.66M
-87.90%13.55M
21.68%9.94M
37,615.49%112.02M
606.75%8.17M
-90.18%297K
-58.71%1.16M
--3.03M
3.28%2.8M
Total non-current assets
-3.17%2.8B
-0.29%2.81B
-13.01%2.89B
68.51%2.81B
205.20%3.33B
74.34%1.67B
17.71%1.09B
25.31%957.79M
--925.86M
2.77%764.36M
Total assets
-22.06%3.9B
-16.45%4.41B
-21.06%5B
3.39%5.28B
17.41%6.33B
18.32%5.11B
54.83%5.39B
17.70%4.32B
--3.48B
254.69%3.67B
Liabilities
Current liabilities
Accounts payable
63.41%40.14M
270.97%33.86M
-16.18%24.56M
4.29%9.13M
279.91%29.31M
65.27%8.75M
92.71%7.71M
264.67%5.3M
--4M
47.71%1.45M
Tax payable
19,266.67%1.16M
-56.91%2.16M
-25.00%6K
942.92%5.01M
--8K
--480K
----
----
--2.2M
-66.91%1.94M
Amounts payable to associated parties-current liabilities
----
----
----
----
----
----
----
----
--685K
0.59%685K
Other payables and accrued expenses
13.63%287.48M
7.61%244.91M
1.85%253.01M
57.25%227.59M
-31.31%248.41M
-59.63%144.73M
0.29%361.62M
-9.61%358.49M
--360.56M
4.14%396.59M
Bank loans and overdrafts
-60.40%130.12M
105.29%456.98M
-23.46%328.57M
4,442.92%222.6M
--429.28M
--4.9M
----
----
----
50.00%120M
Financial lease liabilities-current liabilities
48.67%34.46M
60.81%37.72M
84.56%23.18M
32.32%23.46M
-8.74%12.56M
59.82%17.73M
42.52%13.76M
23.35%11.09M
--9.66M
50.90%8.99M
Other current liabilities
----
----
----
----
-29.27%15.02M
-0.35%14.11M
79.08%21.23M
14.50%14.16M
--11.86M
125.58%12.36M
Special items of current liabilities
----
-48.91%700K
-88.46%1.73M
-90.86%1.37M
0.00%14.99M
6.74%14.99M
-37.65%14.99M
-41.59%14.05M
--24.05M
60.84%24.05M
Total current liabilities
-21.94%494.35M
63.62%805.17M
-16.01%633.27M
135.98%492.1M
78.63%753.96M
-48.58%208.53M
1.59%422.08M
-28.66%405.52M
--415.49M
14.58%568.46M
Net current assets
-59.21%600.8M
-59.39%802.9M
-34.63%1.47B
-38.82%1.98B
-41.96%2.25B
9.35%3.23B
81.19%3.88B
26.50%2.95B
--2.14B
1,236.78%2.34B
Total assets less current liabilities
-22.08%3.4B
-24.68%3.61B
-21.74%4.37B
-2.25%4.79B
12.21%5.58B
25.26%4.9B
62.04%4.97B
26.20%3.91B
--3.07B
476.00%3.1B
Non-current liabilities
Long-term bank loan
-41.03%265.45M
-56.59%248.93M
-9.14%450.12M
--573.38M
--495.38M
----
----
----
----
----
Other loans-non-current liabilities
----
----
----
----
----
----
----
----
--981K
----
Financial lease liabilities-non-current liabilities
-3.85%68.21M
2.93%82.56M
83.11%70.94M
66.58%80.2M
114.60%38.74M
122.18%48.15M
4.20%18.05M
25.18%21.67M
--17.33M
12.75%17.31M
Deferred tax liability
3.78%16.64M
2.10%17.78M
-92.34%16.04M
-67.43%17.41M
561.60%209.43M
62.26%53.45M
-20.99%31.66M
-11.66%32.94M
--40.06M
-3.70%37.29M
Special items of non-current liabilities
-35.03%330.02M
-30.40%339.94M
37.95%507.98M
191.63%488.43M
--368.23M
15,670.24%167.48M
----
--1.06M
----
----
Total non-current liabilities
-34.90%680.32M
-40.56%689.2M
-6.00%1.05B
330.88%1.16B
2,136.62%1.11B
383.30%269.08M
-14.84%49.71M
1.96%55.68M
--58.37M
-19.55%54.6M
Total liabilities
-30.01%1.17B
-9.52%1.49B
-10.04%1.68B
245.79%1.65B
295.46%1.87B
3.56%477.61M
-0.44%471.79M
-25.98%461.19M
--473.86M
10.47%623.06M
Total assets less total liabilities
-18.04%2.72B
-19.61%2.92B
-25.66%3.32B
-21.60%3.63B
-9.24%4.47B
20.09%4.63B
63.53%4.92B
26.64%3.86B
--3.01B
547.52%3.05B
Total equity and non-current liabilities
-22.08%3.4B
-24.68%3.61B
-21.74%4.37B
-2.25%4.79B
12.21%5.58B
25.26%4.9B
62.04%4.97B
26.20%3.91B
--3.07B
476.00%3.1B
Equity
Share capital
0.00%441.01M
0.00%441.01M
0.00%441.01M
0.00%441.01M
0.00%441.01M
4.27%441.01M
9.03%441.01M
4.57%422.97M
--404.47M
34.82%404.47M
Reserve
-20.44%2.28B
-21.70%2.48B
-27.84%2.87B
-22.85%3.17B
-10.46%3.98B
20.99%4.1B
71.12%4.44B
28.87%3.39B
--2.6B
1,529.39%2.63B
Shareholders' Equity
-17.72%2.73B
-19.05%2.92B
-25.06%3.31B
-20.63%3.61B
-9.51%4.42B
19.14%4.55B
62.76%4.89B
25.63%3.82B
--3B
557.98%3.04B
Non-controlling interest
-139.30%-3.43M
-105.55%-1.3M
-81.56%8.72M
-72.80%23.45M
26.28%47.3M
107.19%86.21M
327.91%37.46M
374.58%41.61M
--8.75M
-0.48%8.77M
Total equity
-18.04%2.72B
-19.61%2.92B
-25.66%3.32B
-21.60%3.63B
-9.24%4.47B
20.09%4.63B
63.53%4.92B
26.64%3.86B
--3.01B
547.52%3.05B
Total equity and total liabilities
-22.06%3.9B
-16.45%4.41B
-21.06%5B
3.39%5.28B
17.41%6.33B
18.32%5.11B
54.83%5.39B
17.70%4.32B
--3.48B
254.69%3.67B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Zhonghui Certified Public Accountants
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Assets
Current assets
Inventory 4.99%123.68M8.19%112.94M10.79%117.81M15.33%104.4M60.50%106.33M51.11%90.52M74.94%66.25M141.66%59.9M--37.87M48.57%24.79M
Accounts receivable -32.00%273.1M-4.21%290.61M19.44%401.62M0.43%303.39M-1.64%336.26M30.76%302.1M113.05%341.88M42.44%231.03M--160.47M101.13%162.2M
Related party payments receivable ------------------------------22.5M--------
Advance deposits and other receivables -26.38%94.55M-12.35%105.07M3.01%128.43M34.33%119.87M95.23%124.67M155.07%89.23M-43.01%63.86M-88.47%34.98M--112.06M998.82%303.46M
Cash and equivalents -66.57%485.84M-58.80%774.4M-40.32%1.45B-36.40%1.88B-31.98%2.44B9.12%2.96B81.76%3.58B12.22%2.71B--1.97B1,363.34%2.41B
Short-term deposit ------7.24M--------------------------------
Secured deposit 81.21%9.43M670.00%211.65M8.92%5.2M972.45%27.49M-98.11%4.78M-99.01%2.56M-9.20%252.76M34,714.48%259.72M--278.36M8.75%746K
Financial assets at fair value-current assets ------------------------------44.13M--------
Special items of current assets --108.54M208.63%106.17M------34.4M------------------------
Total current assets -48.00%1.1B-34.87%1.61B-29.96%2.11B-28.22%2.47B-30.14%3.01B2.36%3.44B68.26%4.3B15.70%3.36B--2.56B899.34%2.9B
Non-current assets
Property, plant and equipment 56.31%568.12M70.80%543.37M40.83%363.46M123.67%318.14M144.41%258.09M105.26%142.24M58.20%105.6M14.76%69.3M--66.75M29.21%60.38M
Advance payment -21.09%3.39M-42.31%9.15M-81.75%4.3M-6.35%15.86M-29.82%23.57M-38.03%16.93M-50.59%33.58M309.89%27.32M--67.96M262.23%6.67M
Associated company interest -8.77%60.93M-13.84%60.55M-6.98%66.79M-7.75%70.28M-12.87%71.8M100.51%76.18M1,109.57%82.41M--38M--6.81M----
Interests in Joint Venture -21.34%4.18M75.70%4.79M--5.31M--2.73M------------------------
Financial assets at fair value-non-current assets 3.95%430.81M10.32%428.38M53.08%414.45M-18.62%388.32M87.25%270.74M640.08%477.16M408.92%144.58M--64.47M--28.41M----
Intangible assets -11.52%531.34M-9.84%551.02M-40.26%600.55M100.55%611.17M340.97%1.01B30.79%304.74M14.93%227.97M25.85%233M--198.36M-3.13%185.15M
Goodwill -19.24%1.03B-17.29%1.02B-9.12%1.28B138.31%1.24B191.06%1.4B6.65%519.71M-7.98%482.5M1.60%487.32M--524.36M1.65%479.63M
Deferred tax assets 56.82%21.26M77.65%17.66M-87.90%13.55M21.68%9.94M37,615.49%112.02M606.75%8.17M-90.18%297K-58.71%1.16M--3.03M3.28%2.8M
Total non-current assets -3.17%2.8B-0.29%2.81B-13.01%2.89B68.51%2.81B205.20%3.33B74.34%1.67B17.71%1.09B25.31%957.79M--925.86M2.77%764.36M
Total assets -22.06%3.9B-16.45%4.41B-21.06%5B3.39%5.28B17.41%6.33B18.32%5.11B54.83%5.39B17.70%4.32B--3.48B254.69%3.67B
Liabilities
Current liabilities
Accounts payable 63.41%40.14M270.97%33.86M-16.18%24.56M4.29%9.13M279.91%29.31M65.27%8.75M92.71%7.71M264.67%5.3M--4M47.71%1.45M
Tax payable 19,266.67%1.16M-56.91%2.16M-25.00%6K942.92%5.01M--8K--480K----------2.2M-66.91%1.94M
Amounts payable to associated parties-current liabilities ----------------------------------685K0.59%685K
Other payables and accrued expenses 13.63%287.48M7.61%244.91M1.85%253.01M57.25%227.59M-31.31%248.41M-59.63%144.73M0.29%361.62M-9.61%358.49M--360.56M4.14%396.59M
Bank loans and overdrafts -60.40%130.12M105.29%456.98M-23.46%328.57M4,442.92%222.6M--429.28M--4.9M------------50.00%120M
Financial lease liabilities-current liabilities 48.67%34.46M60.81%37.72M84.56%23.18M32.32%23.46M-8.74%12.56M59.82%17.73M42.52%13.76M23.35%11.09M--9.66M50.90%8.99M
Other current liabilities -----------------29.27%15.02M-0.35%14.11M79.08%21.23M14.50%14.16M--11.86M125.58%12.36M
Special items of current liabilities -----48.91%700K-88.46%1.73M-90.86%1.37M0.00%14.99M6.74%14.99M-37.65%14.99M-41.59%14.05M--24.05M60.84%24.05M
Total current liabilities -21.94%494.35M63.62%805.17M-16.01%633.27M135.98%492.1M78.63%753.96M-48.58%208.53M1.59%422.08M-28.66%405.52M--415.49M14.58%568.46M
Net current assets -59.21%600.8M-59.39%802.9M-34.63%1.47B-38.82%1.98B-41.96%2.25B9.35%3.23B81.19%3.88B26.50%2.95B--2.14B1,236.78%2.34B
Total assets less current liabilities -22.08%3.4B-24.68%3.61B-21.74%4.37B-2.25%4.79B12.21%5.58B25.26%4.9B62.04%4.97B26.20%3.91B--3.07B476.00%3.1B
Non-current liabilities
Long-term bank loan -41.03%265.45M-56.59%248.93M-9.14%450.12M--573.38M--495.38M--------------------
Other loans-non-current liabilities ----------------------------------981K----
Financial lease liabilities-non-current liabilities -3.85%68.21M2.93%82.56M83.11%70.94M66.58%80.2M114.60%38.74M122.18%48.15M4.20%18.05M25.18%21.67M--17.33M12.75%17.31M
Deferred tax liability 3.78%16.64M2.10%17.78M-92.34%16.04M-67.43%17.41M561.60%209.43M62.26%53.45M-20.99%31.66M-11.66%32.94M--40.06M-3.70%37.29M
Special items of non-current liabilities -35.03%330.02M-30.40%339.94M37.95%507.98M191.63%488.43M--368.23M15,670.24%167.48M------1.06M--------
Total non-current liabilities -34.90%680.32M-40.56%689.2M-6.00%1.05B330.88%1.16B2,136.62%1.11B383.30%269.08M-14.84%49.71M1.96%55.68M--58.37M-19.55%54.6M
Total liabilities -30.01%1.17B-9.52%1.49B-10.04%1.68B245.79%1.65B295.46%1.87B3.56%477.61M-0.44%471.79M-25.98%461.19M--473.86M10.47%623.06M
Total assets less total liabilities -18.04%2.72B-19.61%2.92B-25.66%3.32B-21.60%3.63B-9.24%4.47B20.09%4.63B63.53%4.92B26.64%3.86B--3.01B547.52%3.05B
Total equity and non-current liabilities -22.08%3.4B-24.68%3.61B-21.74%4.37B-2.25%4.79B12.21%5.58B25.26%4.9B62.04%4.97B26.20%3.91B--3.07B476.00%3.1B
Equity
Share capital 0.00%441.01M0.00%441.01M0.00%441.01M0.00%441.01M0.00%441.01M4.27%441.01M9.03%441.01M4.57%422.97M--404.47M34.82%404.47M
Reserve -20.44%2.28B-21.70%2.48B-27.84%2.87B-22.85%3.17B-10.46%3.98B20.99%4.1B71.12%4.44B28.87%3.39B--2.6B1,529.39%2.63B
Shareholders' Equity -17.72%2.73B-19.05%2.92B-25.06%3.31B-20.63%3.61B-9.51%4.42B19.14%4.55B62.76%4.89B25.63%3.82B--3B557.98%3.04B
Non-controlling interest -139.30%-3.43M-105.55%-1.3M-81.56%8.72M-72.80%23.45M26.28%47.3M107.19%86.21M327.91%37.46M374.58%41.61M--8.75M-0.48%8.77M
Total equity -18.04%2.72B-19.61%2.92B-25.66%3.32B-21.60%3.63B-9.24%4.47B20.09%4.63B63.53%4.92B26.64%3.86B--3.01B547.52%3.05B
Total equity and total liabilities -22.06%3.9B-16.45%4.41B-21.06%5B3.39%5.28B17.41%6.33B18.32%5.11B54.83%5.39B17.70%4.32B--3.48B254.69%3.67B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Zhonghui Certified Public Accountants--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-2.21%